Education
About Us
Working with TipRanks
Follow Us
Xvivo Perfusion AB (SE:XVIVO)
:XVIVO
XVIVO Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
XVIVO Stock 12 Month Forecast
Average Price Target
kr225.03
▲(27.86% Upside)
| Highest Price Targetkr225.03 | Average Price Targetkr225.03 | Lowest Price Targetkr225.03 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Best Analysts Covering Xvivo Perfusion AB
1 Month
xxx
Success Rate
1/1 ratings generated profit
Average Return
+6.40%
downgraded a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +6.40% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
Average Return
+11.40%
downgraded a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +11.40% per trade.
1 Year
Simon LarssonDanske Bank
Not Ranked
Success Rate
0/0 ratings generated profit
Average Return
0.00%
upgraded a buy rating last month
Copying Simon Larsson's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
Average Return
+47.90%
downgraded a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +47.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
XVIVO Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Oct 25
Nov 25
Strong Buy
2
1
1
1
1
Buy
0
0
0
0
0
Hold
4
7
7
6
4
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
8
8
7
5
Each month's total comprises the sum of three months' worth of ratings.
XVIVO Financial Forecast
XVIVO Stock Forecast FAQ
What is SE:XVIVO’s average 12-month price target, according to analysts?
Based on analyst ratings, Xvivo Perfusion AB’s 12-month average price target is 225.03.
What is SE:XVIVO’s upside potential, based on the analysts’ average price target?
Xvivo Perfusion AB has 27.86% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Xvivo Perfusion AB a Buy, Sell or Hold?
Xvivo Perfusion AB has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Xvivo Perfusion AB’s share price target?
The average share price target for Xvivo Perfusion AB is 225.03. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr225.03 ,and the lowest forecast is kr225.03. The average share price target represents 27.86% Increase from the current price of kr176.
The highest analyst share price target is kr225.03 ,and the lowest forecast is kr225.03. The average share price target represents 27.86% Increase from the current price of kr176.
What do analysts say about Xvivo Perfusion AB?
Xvivo Perfusion AB’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Xvivo Perfusion AB?
To buy shares of SE:XVIVO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.